Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
…, D Cooper, P Cunningham, A Dagnra… - The Lancet infectious …, 2019 - thelancet.com
Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
…, K Chijiwa, D Cooper, P Cunningham, A Dagnra… - The Lancet …, 2020 - thelancet.com
Background Global HIV-1 genetic diversity and evolution form a major challenge to treatment
and prevention efforts. An increasing number of distinct HIV-1 recombinants have been …
and prevention efforts. An increasing number of distinct HIV-1 recombinants have been …
High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in …
Introduction Antiretroviral treatment (ART) has been scaled up over the last decade but compared
to adults, children living with HIV are less likely to receive ART. Moreover, children and …
to adults, children living with HIV are less likely to receive ART. Moreover, children and …
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
…, SM Awoussi, M Djibril, M Mijiyawa, AC Dagnra… - PLoS …, 2020 - journals.plos.org
Background In December 2019, the COVID-19 outbreak began in China and quickly spread
throughout the world and was reclassified as a pandemic in March 2020. The first case of …
throughout the world and was reclassified as a pandemic in March 2020. The first case of …
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health …
…, S Eymard-Duvernay, A Dagnra… - Clinical infectious …, 2014 - academic.oup.com
Background. The limited access to virological monitoring in developing countries is a major
weakness of the current antiretroviral treatment (ART) strategy in these settings. We …
weakness of the current antiretroviral treatment (ART) strategy in these settings. We …
High prevalence of HIV‐1 drug resistance among patients on first‐line antiretroviral treatment in Lome, Togo
AY Dagnra, N Vidal, A Mensah… - Journal of the …, 2011 - Wiley Online Library
Background With widespread use of antiretroviral (ARV) drugs in Africa, one of the major
potential challenges is the risk of emergence of ARV drug‐resistant HIV strains. Our objective is …
potential challenges is the risk of emergence of ARV drug‐resistant HIV strains. Our objective is …
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia
…, S Eymard-Duvernay, A Dagnra… - Journal of clinical …, 2014 - Am Soc Microbiol
Dried blood spots (DBS) can be used in developing countries to alleviate the logistic
constraints of using blood plasma specimens for viral load (VL) and HIV drug resistance (HIVDR) …
constraints of using blood plasma specimens for viral load (VL) and HIV drug resistance (HIVDR) …
Prevalence of human papillomavirus, human immunodeficiency virus, and other sexually transmitted infections among men who have sex with men in Togo: a national …
…, G Collin, AC Dagnra… - Clinical Infectious …, 2019 - academic.oup.com
Background Sub-Saharan Africa is a region of both high human immunodeficiency virus (HIV)
and anal cancer incidence. We conducted the first national study in Togo to assess human …
and anal cancer incidence. We conducted the first national study in Togo to assess human …
The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance
…, K Salako, I Baldeh, A Jallow, M Jallow, A Dagnra… - BMC medicine, 2016 - Springer
Background Drug-resistant tuberculosis (TB) is a global public health problem. Adequate
management requires baseline drug-resistance prevalence data. In West Africa, due to a poor …
management requires baseline drug-resistance prevalence data. In West Africa, due to a poor …
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries
…, THK Huynh, AY Dagnra… - Journal of …, 2019 - academic.oup.com
Background ART in the developing world has moved to a new era with the WHO recommendation
to test and immediately treat HIV-positive individuals. A high frequency of pretreatment …
to test and immediately treat HIV-positive individuals. A high frequency of pretreatment …
